Why screen for alpha1-antitrypsin deficiency? | Genetic testing for alpha-1 скачать в хорошем качестве

Why screen for alpha1-antitrypsin deficiency? | Genetic testing for alpha-1

Watch to learn why screening for alpha-1 is important. Approximately 90% of patients with genetic COPD, also known as alpha-1, are estimated to be undiagnosed.[1-3] Up to 3% of COPD patients in the United States have genetic COPD.[1] Detecting patients with deficient alleles is crucial to confirm the diagnosis of alpha-1 and to confirm if the patient is a carrier.[2-4] Delayed testing for alpha-1 can mean delayed diagnosis and potential treatment for the patient and possibly their family members. Genetic testing is required to determine if a patient has alpha-1.[5] You can learn more at https://bit.ly/3l6mcIq More information about alpha-1: https://bit.ly/38UlfNu Alpha-1 screening guidelines: https://bit.ly/38RNexn Order free AlphaID™ screening kits: https://bit.ly/3DUILbH References: [1] Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003. Chest. 2005;128(3):1179-1186. [2] World Health Organization. α1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997;75(5):397-415. [3] Alpha-1 antitrypsin deficiency. NORD® National Organization for Rare Diseases website. https://rarediseases.org/rare-disease.... Accessed July 12, 2021. [4] MedlinePlus®. Alpha-1 antitrypsin deficiency. https://medlineplus.gov/download/gene.... Updated August 18, 2020. Accessed July 12, 2021. [5] Lung disease. Alpha-1 Foundation website. https://www.alpha1.org/newly-diagnose.... Accessed July 12, 2021.